Literature DB >> 32096024

Ordered Assembly of Tau Protein and Neurodegeneration.

Michel Goedert1, Maria Grazia Spillantini2.   

Abstract

Tau filaments with distinct morphologies and/or isoform compositions underlie a large number of human neurodegenerative diseases. Their formation is important, because dominantly inherited mutations in MAPT, the tau gene, cause frontotemporal dementia with abundant filamentous tau inclusions. Assembly of tau may begin in a specific region of the brain, from where it spreads to other areas. It remains to be seen if the molecular species underlying tau aggregate-mediated neurodegeneration and propagation are the same or different. In the brains of mice transgenic for human mutant P301S tau, small tau filaments are the predominant seed-competent species. It has been suggested that different conformers of assembled tau may give rise to different human tauopathies, but until recently, it was not possible to study this directly. Electron cryo-microscopy can now be used to determine high-resolution structures of amyloid filaments from human brain. Paired helical and straight tau filaments of Alzheimer's disease are ultrastructural polymorphs. Each filament core is composed of two identical protofilaments extending from G273/304-E380 (in the numbering of the 441 amino acid isoform of human tau), which adopt a combined cross-β/β-helix structure. They comprise the ends of the first or second microtubule-binding repeat (R1 or R2), the whole of R3 and R4, as well as 12 amino acids after R4. By contrast, the core of the narrow filament of Pick's disease consists of a single protofilament extending from K254-F378 of 3R tau, which adopts a cross-β structure. It comprises the last 21 amino acids of R1, all of R3 and R4, as well as 10 amino acids after R4. Wide tau filaments of Pick's disease, which are in the minority, consist of two narrow filaments packed against each other. The tau filament folds of Alzheimer's and Pick's diseases appear to be conserved between different cases of disease. These findings show that filamentous tau adopts one fold in Alzheimer's disease and a different fold in Pick's disease, establishing the existence of distinct conformers.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 32096024     DOI: 10.1007/978-981-32-9358-8_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

Review 1.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

Review 2.  Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies.

Authors:  Che-Wei Chang; Eric Shao; Lennart Mucke
Journal:  Science       Date:  2021-02-26       Impact factor: 47.728

Review 3.  The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.

Authors:  Dan Wang; Xianlong Huang; Lu Yan; Luoqi Zhou; Chang Yan; Jinhu Wu; Zhengding Su; Yongqi Huang
Journal:  Protein J       Date:  2021-08-17       Impact factor: 2.371

4.  TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model.

Authors:  Eric Shao; Che-Wei Chang; Zhiyong Li; Xinxing Yu; Kaitlyn Ho; Michelle Zhang; Xin Wang; Jeffrey Simms; Iris Lo; Jessica Speckart; Julia Holtzman; Gui-Qiu Yu; Erik D Roberson; Lennart Mucke
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

5.  Capacity for Seeding and Spreading of Argyrophilic Grain Disease in a Wild-Type Murine Model; Comparisons With Primary Age-Related Tauopathy.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Julia Sala-Jarque; Vanessa Gil; José Antonio Del Rio
Journal:  Front Mol Neurosci       Date:  2020-06-24       Impact factor: 5.639

Review 6.  Zebrafish Models to Study New Pathways in Tauopathies.

Authors:  Clément Barbereau; Nicolas Cubedo; Tangui Maurice; Mireille Rossel
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 7.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

Review 8.  Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core.

Authors:  Elena Vacchi; Alain Kaelin-Lang; Giorgia Melli
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 9.  Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.

Authors:  Matteo Manca; Allison Kraus
Journal:  Biomolecules       Date:  2020-08-25

10.  Beyond Langmuir: surface-bound macromolecule condensates.

Authors:  T J Mitchison
Journal:  Mol Biol Cell       Date:  2020-11-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.